05302017Headline:

Minneapolis, Minnesota

HomeMinnesotaMinneapolis

Email Mike Bryant Mike Bryant on LinkedIn Mike Bryant on Twitter Mike Bryant on Facebook Mike Bryant on Avvo
Mike Bryant
Mike Bryant
Attorney • (800) 770-7008

What is Going On with Johnson & Johnson?

Comments Off

I remember growing us when they were a trusted company. They had the baby stuff that always gave you a warm and comforting feeling. There was the stuff they did, that I didn’t understand at a young age, but seemed like they were helping grown ups. It was one of those names that you felt confidence in.

But the last year and a half hasn’t been kind. Business Week has this list:

AUG 2008

Consultants to J&J buy defective Motrin from stores. The FDA says it wasn’t notified of this "phantom recall."

NOV 2009

McNeil pulls about 6.3 million bottles of tainted Tylenol Arthritis Pain caplets made in Puerto Rico.

JAN 2010

McNeil expands withdrawal to include Benadryl Allergy, Tylenol, Children’s Tylenol Meltaway, and Rolaids.

APR 2010

J&J recalls 135 million bottles of meds made in Fort Washington, Pa., and closes the plant.

MAY 2010

The FDA’s Joshua Sharfstein says the U.S. may pursue criminal charges against J&J.

JUNE 2010

McNeil expands the recall from its Puerto Rico plant to include five more lots of Benadryl and Tylenol.

JULY 2010

Yet more recalls; company submits remediation plan for McNeil plants to FDA.

AUG 2010

Company appoints Ajit Shetty as quality-control czar, announces corporation-wide standards.

AUG 2010

J&J pulls 100,000 boxes of 1-Day Acuvue TruEye contact lenses; days later, DePuy recalls ASR hips.

DEC 2010

13 million packages of Rolaids softchews are recalled after customers find wood and metal particles in them.

JAN 2011

J&J withdraws 43 million bottles of Rolaids, Tylenol, Benadryl, and Sinutab.

JAN 2011

J&J announces 2010 earnings, puts lost sales from recalls and plant slowdowns at $900 million.

FEB 2011

J&J units announce recalls of 70,000 potentially cracked syringes preloaded with the antipsychotic Invega.

MAR 2011

J&J withdraws 585,000 surgical sutures due to concerns about compromised sterile packaging.

MAR 2011

David Floyd, president of DePuy Orthopaedics, announces his resignation.

MAR 2011

J&J’s Animas unit announces recall of 384,000 insulin-pump cartridges that may leak.

MAR 2011

FDA and McNeil announce consent decree that will give agency expanded oversight of three plants.

Here at the Injuryboard there have been a number of articles about each of these recalls. Maybe between the governmental reviews and the litigation that will come out of some of the injuries, more will be done to figure out what happened and why.